Search Results - "ZHOU, LUQIAN"
-
1
Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
Published in The lancet respiratory medicine (01-03-2020)Get full text
Journal Article -
2
Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice
Published in Critical care (London, England) (11-06-2020)“…[...]NIV median daily usage was only 8 h. Furthermore, high expiratory tidal volume (9.2 ± 3.0 mL/kg) and low PEEP (5 cmH2O) may have negative impact on the…”
Get full text
Journal Article -
3
Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD
Published in Frontiers in pharmacology (24-03-2022)“…Chronic obstructive pulmonary disease (COPD) is a severely disabling chronic lung disease characterized by persistent airway inflammation, which leads to…”
Get full text
Journal Article -
4
Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis
Published in European journal of medical research (15-09-2023)“…Abstract Background The role of prophylactic antibiotics in preventing ventilator-associated pneumonia (VAP) in patients undergoing invasive mechanical…”
Get full text
Journal Article -
5
Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China
Published in BioScience Trends (31-08-2020)“…This study aimed to determine the clinical significance of Krebs von den Lungen-6 (KL-6) in patients with COVID-19, so as to find a marker with high…”
Get full text
Journal Article -
6
Combination of inspiratory and expiratory muscle training in same respiratory cycle versus different cycles in COPD patients: a randomized trial
Published in Respiratory research (20-11-2018)“…Difference between combined inspiratory and expiratory muscle training in same respiratory cycle or different cycles remained unclarified. We explored the…”
Get full text
Journal Article -
7
Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients
Published in International journal of biological sciences (01-01-2021)“…Dysregulated immune response and abnormal repairment could cause secondary pulmonary fibrosis of varying severity in COVID-19, especially for the elders. The…”
Get full text
Journal Article -
8
Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD
Published in Respiratory care (01-05-2016)“…Despite the high prevalence of weight loss in subjects with COPD, the 2011 COPD management guidelines do not include an index measuring nutritional status…”
Get full text
Journal Article -
9
Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin
Published in Molecular therapy. Nucleic acids (07-12-2018)“…Non-coding RNAs play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). The aim of this study was to characterize the therapeutic…”
Get full text
Journal Article -
10
The link between ferroptosis and airway inflammatory diseases: A novel target for treatment
Published in Frontiers in molecular biosciences (17-08-2022)“…Ferroptosis is an iron-dependent mode of cell death characterized by intracellular lipid peroxide accumulation and a redox reaction imbalance. Compared with…”
Get full text
Journal Article -
11
Pulmonary actinomycosis diagnosed by transbronchoscopic lung biopsy: A case report and literature review
Published in Experimental and therapeutic medicine (01-09-2018)“…Pulmonary actinomycosis is a chronic, suppurative, granulomatous disease caused by , an obligate anaerobe. The clinical manifestations and imaging…”
Get full text
Journal Article -
12
Efficacy of positive airway pressure therapy and high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: A protocol for systematic review and network meta-analysis
Published in Frontiers in medicine (07-12-2022)“…Positive airway pressure (PAP) therapy is currently the first-line respiratory support technique for acute respiratory failure (ARF) due to acute cardiogenic…”
Get full text
Journal Article -
13
Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis
Published in Frontiers in medicine (23-11-2022)“…JAK (Janus kinases) inhibitors have been proposed as a promising treatment option for the coronavirus disease-2019 (COVID-19). However, the benefits of JAK…”
Get full text
Journal Article -
14
Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19
Published in ERJ open research (01-01-2021)“…Critically ill coronavirus disease 2019 (COVID-19) patients may suffer persistent systemic inflammation and multiple organ failure, leading to a poor…”
Get full text
Journal Article -
15
Helmet CPAP versus Oxygen Therapy in Hypoxemic Acute Respiratory Failure: A Meta-Analysis of Randomized Controlled Trials
Published in Yonsei medical journal (01-07-2016)“…The efficacy of helmet continuous positive airway pressure (CPAP) in hypoxemic acute respiratory failure (hARF) remains unclear. The aim of this meta-analysis…”
Get full text
Journal Article -
16
Improved mechanical ventilation requires more than just increased ventilator availability: A word of caution
Published in Clinical and translational medicine (01-06-2020)Get full text
Journal Article -
17
More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
Published in The European respiratory journal (01-03-2020)“…As of 17 February, 2020, China has 70 635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths [1]. Human-to-human spread of the virus…”
Get full text
Journal Article -
18
Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease‐2019 (COVID‐19): A systematic review and meta‐analysis
Published in Journal of medical virology (01-04-2022)“…The benefits of baricitinib in coronavirus disease‐2019 are inadequately defined. We performed a systematic review and meta‐analysis of studies of baricitinib…”
Get full text
Journal Article -
19
-
20